News

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health ...
GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced ... may cut that risk by nearly 50% — an approach that would ...
Bad reactions to popular weight-loss drugs, including Ozempic and Wegovy, are on track to soar by more than 350 per cent within a year, new data has suggested. Figures from the UK's drugs ...
Caroline Manzo’s daughter, Lauren Manzo, admitted she used the weight-loss drug Mounjaro, a competitor of Ozempic, to lose 30 pounds following a 50-pound weight loss. “You guys have seen me ...
There was one clear winner. Mounjaro helped people achieve 50% more weight loss than Ozempic. Those taking Mounjaro lost on average 20% of their body weight. In that same period, patients using ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication ... it's only a matter of time until Ozempic-like drugs are available ...
Novo Nordisk, which also makes Wegovy, fell victim to 'compounding' - a practice in the US that allows pharmacies to produce ...